These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 17618300)

  • 1. The kinin B1 receptor antagonist SSR240612 reverses tactile and cold allodynia in an experimental rat model of insulin resistance.
    Dias JP; Ismael MA; Pilon M; de Champlain J; Ferrari B; Carayon P; Couture R
    Br J Pharmacol; 2007 Sep; 152(2):280-7. PubMed ID: 17618300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinin B1 receptor enhances the oxidative stress in a rat model of insulin resistance: outcome in hypertension, allodynia and metabolic complications.
    Dias JP; Talbot S; Sénécal J; Carayon P; Couture R
    PLoS One; 2010 Sep; 5(9):e12622. PubMed ID: 20830306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of kinin B1 receptor and oxidative stress in sensory abnormalities and arterial hypertension in an experimental rat model of insulin resistance.
    Lungu C; Dias JP; França CE; Ongali B; Regoli D; Moldovan F; Couture R
    Neuropeptides; 2007 Dec; 41(6):375-87. PubMed ID: 17988733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blockade of sensory abnormalities and kinin B(1) receptor expression by N-acetyl-L-cysteine and ramipril in a rat model of insulin resistance.
    Ismael MA; Talbot S; Carbonneau CL; Beauséjour CM; Couture R
    Eur J Pharmacol; 2008 Jul; 589(1-3):66-72. PubMed ID: 18555989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of vascular inflammation by kinin B1 receptor antagonism in a rat model of insulin resistance.
    Dias JP; Couture R
    J Cardiovasc Pharmacol; 2012 Jul; 60(1):61-9. PubMed ID: 22494994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blockade of kinin B(1) receptor reverses plasma fatty acids composition changes and body and tissue fat gain in a rat model of insulin resistance.
    Dias JP; Couture R
    Diabetes Obes Metab; 2012 Mar; 14(3):244-53. PubMed ID: 22023455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Key role for spinal dorsal horn microglial kinin B1 receptor in early diabetic pain neuropathy.
    Talbot S; Chahmi E; Dias JP; Couture R
    J Neuroinflammation; 2010 Jun; 7(1):36. PubMed ID: 20587056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SSR240612 [(2R)-2-[((3R)-3-(1,3-benzodioxol-5-yl)-3-[[(6-methoxy-2-naphthyl)sulfonyl]amino]propanoyl)amino]-3-(4-[[2R,6S)-2,6-dimethylpiperidinyl]methyl]phenyl)-N-isopropyl-N-methylpropanamide hydrochloride], a new nonpeptide antagonist of the bradykinin B1 receptor: biochemical and pharmacological characterization.
    Gougat J; Ferrari B; Sarran L; Planchenault C; Poncelet M; Maruani J; Alonso R; Cudennec A; Croci T; Guagnini F; Urban-Szabo K; Martinolle JP; Soubrié P; Finance O; Le Fur G
    J Pharmacol Exp Ther; 2004 May; 309(2):661-9. PubMed ID: 14747609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beneficial effects of kinin B1 receptor antagonism on plasma fatty acid alterations and obesity in Zucker diabetic fatty rats.
    Talbot S; Dias JP; El Midaoui A; Couture R
    Can J Physiol Pharmacol; 2016 Jul; 94(7):752-7. PubMed ID: 27172260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain kinin B1 receptor is upregulated by the oxidative stress and its activation leads to stereotypic nociceptive behavior in insulin-resistant rats.
    Dias JP; Gariépy Hde B; Ongali B; Couture R
    Peptides; 2015 Jul; 69():118-26. PubMed ID: 25959537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of kinin B1 and B2 receptors in a rat model of neuropathic pain.
    Petcu M; Dias JP; Ongali B; Thibault G; Neugebauer W; Couture R
    Int Immunopharmacol; 2008 Feb; 8(2):188-96. PubMed ID: 18182225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tactile allodynia and formalin hyperalgesia in streptozotocin-diabetic rats: effects of insulin, aldose reductase inhibition and lidocaine.
    Calcutt NA; Jorge MC; Yaksh TL; Chaplan SR
    Pain; 1996 Dec; 68(2-3):293-9. PubMed ID: 9121817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of α-lipoic acid on liver peroxisome proliferator-activated receptor-α, vascular remodeling, and oxidative stress in insulin-resistant rats.
    El Midaoui A; Lungu C; Wang H; Wu L; Robillard C; Deblois D; Couture R
    Can J Physiol Pharmacol; 2011 Oct; 89(10):743-51. PubMed ID: 21919742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Face-to-face comparison of the predictive validity of two models of neuropathic pain in the rat: analgesic activity of pregabalin, tramadol and duloxetine.
    Le Cudennec C; Castagné V
    Eur J Pharmacol; 2014 Jul; 735():17-25. PubMed ID: 24726848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peripheral kinin B(1) and B(2) receptor-operated mechanisms are implicated in neuropathic nociception induced by spinal nerve ligation in rats.
    Werner MF; Kassuya CA; Ferreira J; Zampronio AR; Calixto JB; Rae GA
    Neuropharmacology; 2007 Jul; 53(1):48-57. PubMed ID: 17555775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ABT-627, an endothelin ET(A) receptor-selective antagonist, attenuates tactile allodynia in a diabetic rat model of neuropathic pain.
    Jarvis MF; Wessale JL; Zhu CZ; Lynch JJ; Dayton BD; Calzadilla SV; Padley RJ; Opgenorth TJ; Kowaluk EA
    Eur J Pharmacol; 2000 Jan; 388(1):29-35. PubMed ID: 10657544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of hypertension, hyperglycemia and vascular oxidative stress by aspirin treatment in chronically glucose-fed rats.
    El Midaoui A; Wu R; de Champlain J
    J Hypertens; 2002 Jul; 20(7):1407-12. PubMed ID: 12131538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increases of spinal kinin receptor binding sites in two rat models of insulin resistance.
    El Midaoui A; Ongali B; Petcu M; Rodi D; de Champlain J; Neugebauer W; Couture R
    Peptides; 2005 Aug; 26(8):1323-30. PubMed ID: 16042974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Argan Oil as an Effective Nutri-Therapeutic Agent in Metabolic Syndrome: A Preclinical Study.
    El Midaoui A; Haddad Y; Filali-Zegzouti Y; Couture R
    Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29165388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of glucose and insulin on the development of oxidative stress and hypertension in animal models of type 1 and type 2 diabetes.
    El Midaoui A; de Champlain J
    J Hypertens; 2005 Mar; 23(3):581-8. PubMed ID: 15716700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.